IntriCon Corporation

14.43-0.3600-2.43%Vol 18.31K1Y Perf -26.47%
Jan 21st, 2022 16:00 DELAYED
BID14.10 ASK14.43
Open14.87 Previous Close14.79
Pre-Market- After-Market-
 - -  - -%
Target Price
26.50 
Analyst Rating
Strong Buy 1.50
Potential %
83.65 
Finscreener Ranking
★★★★     53.14
Insiders Trans % 3/6/12 mo.
-/-/-100 
Value Ranking
★★+     48.56
Insiders Value % 3/6/12 mo.
-/-/-100 
Growth Ranking
★★★     53.36
Insiders Shares Cnt. % 3/6/12 mo.
-/-/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
12.49 
Earnings Rating
Strong Sell
Market Cap131.93M 
Earnings Date
24th Feb 2022
Alpha0.01 Standard Deviation0.17
Beta1.29 

Today's Price Range

14.1115.30

52W Range

12.4728.16

5 Year PE Ratio Range

-22.90284.40

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-8.26%
1 Month
-3.80%
3 Months
-17.92%
6 Months
-35.55%
1 Year
-26.47%
3 Years
-47.87%
5 Years
96.33%
10 Years
103.24%

TickerPriceChg.Chg.%
IIN14.43-0.3600-2.43
AAPL162.41-2.1000-1.28
GOOG2 601.84-68.2900-2.56
MSFT296.03-5.5700-1.85
XOM72.17-1.1000-1.50
WFC53.67-1.3300-2.42
JNJ164.87-0.3800-0.23
FB303.17-13.3900-4.23
GE96.30-1.9500-1.98
JPM145.08-2.5800-1.75
Financial StrengthValueIndustryS&P 500US Markets
2.50
3.70
0.04
0.06
-
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
25.20
0.80
5.10
0.00
-0.09
RevenueValueIndustryS&P 500US Markets
93.03M
10.18
2.81
8.20
Earnings HistoryEstimateReportedSurprise %
Q03 2021-0.080.12250.00
Q02 20210.080.23187.50
Q01 20210.000.26-
Q04 20200.020.12500.00
Q03 2020-0.050.07240.00
Q02 2020-0.29-0.0293.10
Q01 2020-0.11-0.22-100.00
Q04 2019-0.060.08233.33
Earnings Per EndEstimateRevision %Trend
12/2021 QR0.00-100.00Negative
12/2021 FY0.6715.52Positive
3/2022 QR0.06-57.14Negative
12/2022 FY0.39-17.02Negative
Next Report Date24th Feb 2022
Estimated EPS Next Report-
Estimates Count2
EPS Growth Next 5 Years %12.00
Volume Overview
Volume18.31K
Shares Outstanding9.14M
Shares Float8.58M
Trades Count364
Dollar Volume286.02K
Avg. Volume20.91K
Avg. Weekly Volume11.66K
Avg. Monthly Volume26.97K
Avg. Quarterly Volume36.23K

IntriCon Corporation (NASDAQ: IIN) stock closed at 14.43 per share at the end of the most recent trading day (a -2.43% change compared to the prior day closing price) with a volume of 18.31K shares and market capitalization of 131.93M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 780 people. IntriCon Corporation CEO is Scott Longval.

The one-year performance of IntriCon Corporation stock is -26.47%, while year-to-date (YTD) performance is -10.76%. IIN stock has a five-year performance of 96.33%. Its 52-week range is between 12.47 and 28.16, which gives IIN stock a 52-week price range ratio of 12.49%

IntriCon Corporation currently has a PE ratio of 143.00, a price-to-book (PB) ratio of 1.55, a price-to-sale (PS) ratio of 1.55, a price to cashflow ratio of 16.20, a PEG ratio of 2.32, a ROA of 0.81%, a ROC of 1.01% and a ROE of 1.06%. The company’s profit margin is -0.09%, its EBITDA margin is 5.10%, and its revenue ttm is $93.03 Million , which makes it $10.18 revenue per share.

Of the last four earnings reports from IntriCon Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. IntriCon Corporation’s next earnings report date is 24th Feb 2022.

The consensus rating of Wall Street analysts for IntriCon Corporation is Strong Buy (1.5), with a target price of $26.5, which is +83.65% compared to the current price. The earnings rating for IntriCon Corporation stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

IntriCon Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

IntriCon Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 23.11, ATR14 : 1.02, CCI20 : -196.09, Chaikin Money Flow : 0.05, MACD : -0.32, Money Flow Index : 35.08, ROC : -8.26, RSI : 39.76, STOCH (14,3) : 13.39, STOCH RSI : 0.00, UO : 36.30, Williams %R : -86.61), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of IntriCon Corporation in the last 12-months were: Dennis L. Gonsior (Sold 0 shares of value $-93 900 ), Dennis L. Gonsior (Sold 22 852 shares of value $559 190 ), Michael P. Geraci (Sold 0 shares of value $-161 850 ), Michael P. Geraci (Sold 12 235 shares of value $256 388 ), Nicholas A. Giordano (Option Excercise at a value of $0), Scott Longval (Sold 0 shares of value $-93 900 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (50.00 %)
1 (50.00 %)
1 (50.00 %)
Moderate Buy
1 (50.00 %)
1 (50.00 %)
1 (50.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.50
Strong Buy
1.50
Strong Buy
1.50

IntriCon Corporation

IntriCon Corp design, develop and manufacture miniature and micro-miniature body-worn medical and electronics products. The company has two operating segments, the Body-Worn Device segment (consisting of three markets: medical, hearing health, and professional audio), and the Hearing Health Direct-to-Consumer segment. Its primary geographic markets are the United States, Europe, Asia, and all other countries. The company serves a diverse range of markets including the hearing healthcare market, the medical biotelemetry market, and the professional audio communication market.

CEO: Scott Longval

Telephone: +1 651 636-9770

Address: 1260 Red Fox Road, Arden Hills 55112, MN, US

Number of employees: 780

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

57%43%

Bearish Bullish

72%28%

News

Stocktwits